OncoSil Medical LtdASX: OSL

Investor Webinar Presentation

· Issued by OncoSil Medical Ltd via ASX

Filed with ASX ·

Investor Webinar FDA Approval: A New Chapter for OncoSil CEO & Managing Director, Nigel Lange 17 August 2026 Disclaimer This Presentation has been prepared by OncoSil Medical Ltd (ASX:OSL) ( OncoSil, OSL or the Company ) to provide a general overview of the Company. This Presentation and...

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

In the deck

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases